Northern Trust Corp Acquires 11,705 Shares of Safeguard Scientifics, Inc (SFE)

Northern Trust Corp increased its position in Safeguard Scientifics, Inc (NYSE:SFE) by 4.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 257,886 shares of the asset manager’s stock after buying an additional 11,705 shares during the period. Northern Trust Corp owned about 1.25% of Safeguard Scientifics worth $3,301,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of SFE. SG Americas Securities LLC bought a new position in Safeguard Scientifics in the 2nd quarter worth $141,000. Wells Fargo & Company MN boosted its holdings in Safeguard Scientifics by 58.9% in the 1st quarter. Wells Fargo & Company MN now owns 24,192 shares of the asset manager’s stock worth $296,000 after buying an additional 8,964 shares during the period. Millennium Management LLC boosted its holdings in Safeguard Scientifics by 125.6% in the 1st quarter. Millennium Management LLC now owns 67,787 shares of the asset manager’s stock worth $830,000 after buying an additional 37,739 shares during the period. Legal & General Group Plc boosted its holdings in Safeguard Scientifics by 13.8% in the 2nd quarter. Legal & General Group Plc now owns 87,683 shares of the asset manager’s stock worth $1,122,000 after buying an additional 10,639 shares during the period. Finally, Prescott Group Capital Management L.L.C. bought a new position in Safeguard Scientifics in the 2nd quarter worth $1,406,000. 73.22% of the stock is owned by institutional investors.

Several research analysts recently weighed in on SFE shares. Zacks Investment Research raised shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a report on Tuesday, July 31st. ValuEngine downgraded shares of Safeguard Scientifics from a “hold” rating to a “sell” rating in a report on Monday, July 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Safeguard Scientifics presently has an average rating of “Hold” and a consensus target price of $18.13.

SFE opened at $8.31 on Monday. Safeguard Scientifics, Inc has a 52 week low of $7.98 and a 52 week high of $13.95. The stock has a market cap of $171.58 million, a price-to-earnings ratio of -1.91 and a beta of 1.18. The company has a quick ratio of 2.58, a current ratio of 2.58 and a debt-to-equity ratio of 0.76.

Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, October 25th. The asset manager reported $1.56 EPS for the quarter, missing the consensus estimate of $1.61 by ($0.05). On average, sell-side analysts forecast that Safeguard Scientifics, Inc will post -0.89 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was published by WKRB News and is owned by of WKRB News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.wkrb13.com/2018/11/26/northern-trust-corp-acquires-11705-shares-of-safeguard-scientifics-inc-sfe.html.

Safeguard Scientifics Profile

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Featured Article: What does cost of debt say about a company’s financial health?

Institutional Ownership by Quarter for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply